Genzyme parent wins OK for MS drug - Breaking News Allvoices

News Stories Related To: Genzyme parent wins OK for MS drug

Source: Boston Globe
Paris : France | over 1 year ago  
Sept. 12 (Bloomberg)Sanofi won U.S. clearance for its multiple sclerosis treatment Aubagio, enabling the French drugmaker to enter a $12 billion industry. The Food and Drug Administration...
    • Clear
    • Share:
    • Share
    • Clear
    • Clear
    • Clear
    • Clear
     
  • Read full report
Credibility Credibility of 3

Related news stories

  • Sanofi multiple sclerosis pill gets US approval

      Fox News | over 1 year ago
    The drug has been shown to be less effective than some rivals but has milder side effects and analysts say it could find favor among newly diagnosed patients. Around 35 percent to 40 percent of multiple sclerosis (MS) sufferers prefer to take no...
  • Sanofi multiple sclerosis pill gets U.S. approval

      Reuters | over 1 year ago
    Topics Sanofi CEO Christopher Viehbacher addresses the Boston College's Chief Executives Club of Boston in Massachusetts March 6, 2012. French drugmaker Sanofi SA gained U.S. approval for its multiple sclerosis pill, Aubagio, on Wednesday -- one of...
  • FDA approves Genzyme Corp.'s pill for treating multiple sclerosis

      Boston Globe | over 1 year ago
    The positive ruling for the Cambridge biotechnology company's therapy, called Aubagio, marks the Food and Drug Administration's first approval of a Genzyme drug since French pharmaceutical giant Sanofi SA bought Genzyme for $20.1 billion in 2010.


Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.